Both Th2 and Th1 chemokines (TARC/CCL17, MDC/CCL22, and Mig/CXCL9) are elevated in sera from patients with atopic dermatitis

Journal of Dermatological Science

Volumn 34, Issue 3, 2004, Pages 201-208

  Shimada, Yuka ^a   Takehara, Kazuhiko ^a   Sato, Shinichi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

Atopic dermatitis; MDC CCL22; Mig CXCL9; TARC CCL17

Indexed keywords

CHEMOKINE; CXCL9 CHEMOKINE; IMMUNOGLOBULIN E; MACROPHAGE DERIVED CHEMOKINE; THYMUS AND ACTIVATION REGULATED CHEMOKINE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; ATOPIC DERMATITIS; CHILD; CONTACT DERMATITIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; EOSINOPHILIA; FEMALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TH1 CELL; TH2 CELL;

ADOLESCENT; ADULT; CHEMOKINES, CC; CHEMOKINES, CXC; CHILD; DERMATITIS, ATOPIC; DERMATITIS, CONTACT; FEMALE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; TH1 CELLS; TH2 CELLS;

EID: 2142695686     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2004.01.001     Document Type: Article

References (45)

1. Leung D.Y., Soter N.A., Cellular and immunologic mechanisms in atopic dermatitis J. Am. Acad. Dermatol. 44:2001;S1-S12
2. Beltrani V.S. The clinical spectrum of atopic dermatitis. J. Allerg. Clin. Immunol. 104:1999;S87-S98
3. Tedder T.F., Steeber D.A., Chen A., Engel P. The selectins: vascular adhesion molecules. FASEB J. 9:1995;866-873
4. Baggiolini M. Chemokines and leukocyte traffic. Nature. 392:1998;565-568
5. Baggiolini M., Dewald B., Moser B. Human chemokines: an update. Annu. Rev. Immunol. 15:1997;675-705
6. Rollins B.J. Chemokines. Blood. 90:1997;909-928
7. Bonecchi R., Bianchi G., Bordignon P.P., et al. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J. Exp. Med. 187:1998;129-134
8. Sallusto F., Lenig D., Mackay C.R., Lanzavecchia A. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J. Exp. Med. 187:1998;875-883
9. Loetscher P., Uguccioni M., Bordoli L., et al. CCR5 is characteristic of Th1 lymphocytes [letter]. Nature. 391:1998;344-345
10. Sallusto F., Mackay C.R., Lanzavecchia A. Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science. 277:1997;2005-2007
11. Imai T., Nagira M., Takagi S., et al. Selective recruitment of CCR4-bearing Th2 cells toward antigen-presenting cells by the CC chemokines thymus and activation-regulated chemokine and macrophage-derived chemokine. Int. Immunol. 11:1999;81-88
12. Zingoni A., Soto H., Hedrick J.A., et al. The chemokine receptor CCR8 is preferentially expressed in Th2 but not Th1 cells. J. Immunol. 161:1998;547-551
13. + T lymphocytes are increased in peripheral blood and lesional skin from patients with atopic dermatitis. J. Allerg. Clin. Immunol. 107:2001;353-358
14. Kakinuma T., Nakamura K., Wakugawa M., et al. Thymus and activation-regulated chemokine in atopic dermatitis: serum thymus and activation-regulated chemokine level is closely related with disease activity. J. Allergy Clin. Immunol. 107:2001;535-541
15. Chang M., McNinch J., Elias C. 3rd, et al. Molecular cloning and functional characterization of a novel CC chemokine, stimulated T cell chemotactic protein (STCP-1) that specifically acts on activated T lymphocytes. J. Biol. Chem. 272:1997;25229-25237
16. Godiska R., Chantry D., Raport C.J., et al. Human macrophage-derived chemokine (MDC), a novel chemoattractant for monocytes, monocyte-derived dendritic cells, and natural killer cells. J. Exp. Med. 185:1997;1595-1604
17. Zlotnik A., Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity. 12:2000;121-127
18. Imai T., Chantry D., Raport C.J., et al. Macrophage-derived chemokine is a functional ligand for the CC chemokine receptor 4. J. Biol. Chem. 273:1998;1764-1768
19. Nickel R., Beck L.A., Stellato C., Schleimer R.P. Chemokines and allergic disease. J. Allergy Clin. Immunol. 104:1999;723-742
20. Sallusto F., Schaerli P., Loetscher P., et al. Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation. Eur. J. Immunol. 28:1998;2760-2769
21. Sallusto F., Palermo B., Lenig D., et al. Distinct patterns and kinetics of chemokine production regulate dendritic cell function. Eur. J. Immunol. 29:1999;1617-1625
22. Kakinuma T., Nakamura K., Wakugawa M., et al. Serum macrophage-derived chemokine (MDC) levels are closely related with the disease activity of atopic dermatitis. Clin. Exp. Immunol. 127:2002;270-273
23. Weng Y., Siciliano S.J., Waldburger K.E., et al. Binding and functional properties of recombinant and endogenous CXCR3 chemokine receptors. J. Biol. Chem. 273:1998;18288-18291
24. Liao F., Rabin R.L., Yannelli J.R., Koniaris L.G., Vanguri P., Farber J.M. Human Mig chemokine: biochemical and functional characterization. J. Exp. Med. 182:1995;1301-1314
25. Loetscher M., Gerber B., Loetscher P., et al. Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes. J. Exp. Med. 184:1996;963-969
26. Bos J.D., Wierenga E.A., Sillevis Smitt J.H., van der Heijden F.L., Kapsenberg M.L. Immune dysregulation in atopic eczema. Arch. Dermatol. 128:1992;1509-1512
27. Sager N., Feldmann A., Schilling G., Kreitsch P., Neumann C. House dust mite-specific T cells in the skin of subjects with atopic dermatitis: frequency and lymphokine profile in the allergen patch test. J. Allergy Clin. Immunol. 89:1992;801-810
28. Hamid Q., Naseer T., Minshall E.M., Song Y.L., Boguniewicz M., Leung D.Y. In vivo expression of IL-12 and IL-13 in atopic dermatitis. J. Allergy Clin. Immunol. 98:1996;225-231
29. Leung D.Y. Pathogenesis of atopic dermatitis. J. Allergy Clin. Immunol. 104:1999;S99-108
30. Grewe M., Gyufko K., Schopf E., Krutmann J. Lesional expression of interferon-gamma in atopic eczema. Lancet. 343:1994;25-26
31. Tsicopoulos A., Hamid Q., Haczku A., et al. Kinetics of cell infiltration and cytokine messenger RNA expression after intradermal challenge with allergen and tuberculin in the same atopic individuals. J. Allergy Clin. Immunol. 94:1994;764-772
32. Werfel T., Morita A., Grewe M., et al. Allergen specificity of skin-infiltrating T cells is not restricted to a type-2 cytokine pattern in chronic skin lesions of atopic dermatitis. J. Invest. Dermatol. 107:1996;871-876
33. Thepen T., Langeveld-Wildschut E.G., Bihari I.C., et al. Biphasic response against aeroallergen in atopic dermatitis showing a switch from an initial TH2 response to a TH1 response in situ: an immunocytochemical study. J. Allergy Clin. Immunol. 97:1996;828-837
34. Grewe M., Bruijnzeel-Koomen C.A.F.M., Schopf E., et al. A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis. Immunol. Today. 19:1998;359-361
35. Hanifin J.M., Rajka G. Diagnostic features of atopic dermatitis. Acta Dermatol. Venereol. (Stockh) Suppl. 92:1980;44-47
36. Rajka G., Langeland T. Grading of severity of atopic dermatitis. Acta Dermatol. Venerol. 144:1989;13-14
37. Plaut M. Antigen-specific lymphokine secretory patterns in atopic disease. J. Immunol. 144:1990;4497-4500
38. Wierenga E.A., Snoek M., Jansen H.M., Bos J.D., van Lier R.A., Kapsenberg M.L. Human atopen-specific types 1 and 2 T helper cell clones. J. Immunol. 147:1991;2942-2949
39. Kay A.B., Ying S., Varney V., et al. Messenger RNA expression of the cytokine gene cluster, interleukin 3 (IL-3), IL-4, IL-5, and granulocyte/macrophage colony-stimulating factor, in allergen-induced late-phase cutaneous reactions in atopic subjects. J. Exp. Med. 173:1991;775-778
40. Balashov K.E., Rottman J.B., Weiner H.L., Hancock W.W. CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions. Proc. Natl. Acad. Sci. U.S.A. 96:1999;6873-6878
41. Qin S., Rottman J.B., Myers P., et al. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J. Clin. Invest. 101:1998;746-754
42. Romagnani P., Rotondi M., Lazzeri E., et al. Expression of IP-10/CXCL10 and MIG/CXCL9 in the thyroid and increased levels of IP-10/CXCL10 in the serum of patients with recent-onset Graves' disease. Am. J. Pathol. 161:2002;195-206
43. Ohmen J.D., Hanifin J.M., Nickoloff B.J., et al. Overexpression of IL-10 in atopic dermatitis. Contrasting cytokine patterns with delayed-type hypersensitivity reactions. J. Immunol. 154:1995;1956-1963
44. Tsicopoulos A., Hamid Q., Varney V., et al. Preferential messenger RNA expression of Th1-type cells (IFN-gamma+, IL-2+) in classical delayed-type (tuberculin) hypersensitivity reactions in human skin. J. Immunol. 148:1992;2058-2061
45. Goebeler M., Trautmann A., Voss A., Brocker E.V., Toksoy A., Gillitzer R. Differential and sequential expression of multiple chemokines during elicitation of allergic contact hypersensitivity. Am. J. Pathol. 158:2001;431-440